Skip to the reading
The primer

The practical questions

Ask about the medicine before the package.

With telehealth, the conversation happens by phone, video or an online exchange.

Bring the names of medicines you take, any past test results you have and the question you most want answered.

Who is actually assessing me?

Ask who reviews your health history and whether you can ask that person follow-up questions.

During a remote visit, where you are sets which state must license or otherwise permit the doctor, according to guidance reviewed September 26, 2026.

States each decide their rules, including which exceptions apply.

Ask which licence or state exception the doctor relies on, then ask that state’s medical board to confirm it.

The Federation of State Medical Boards represents those boards.

Its guidance holds remote and in-person care to an equal standard.

This guidance is a model for state boards; it is not itself state law.

If further tests are needed, guidance requires the doctor to carry them out, arrange for them or refer you elsewhere for those tests.

Source a

What does “compounded” mean for this medicine?

Compounding means preparing a medicine from ingredients to meet a patient’s needs.

The FDA is the US Food and Drug Administration, which reviews medicines.

Compounded medicines had no FDA approval on the review date, September 26, 2026.

Compounded medicines get no FDA check before sale on safety, on whether they work or on how well they were made.

Ask what need in your case calls for a medicine prepared to order.

Source b

Can a pharmacy make sermorelin?

“Sermorelin acetate” names the chemical form of sermorelin that was in Geref, the old approved medicine.

Another chemical form of sermorelin is a different ingredient under these rules, so the full name matters.

For a prescription naming one patient, a pharmacy licensed by the state may make sermorelin acetate under federal rules reviewed September 28, 2026.

That depends on meeting the other federal requirements and the rules in your state.

For example, FDA registration is required for the maker of the ingredient, which must also come with a document showing its quality test results.

Any official quality standards that apply to the ingredient must be met; the rules also restrict routine copying of medicines currently on sale.

This explains how general rules may apply; it is not a specific FDA permission for sermorelin.

Meeting the pharmacy rules does not mean FDA has approved the medicine it makes.

Ask the pharmacist to write down the full ingredient name and explain how the preparation meets federal rules and your state’s requirements.

Source c

How can I find out the full cost?

On September 28, 2026, there was no FDA-approved sermorelin product being sold, so no drug-maker or government price was available.

The pharmacy or clinic sets the patient’s price; the missing drug-maker price does not tell you what you would pay.

This guide has no patient price range to offer. To work out what you can afford, ask for a written total covering each item below.

Source d
The visit
Is the assessment charged on its own?
The medicine
Which pharmacy sets this part of the bill?
The tests
What is included, and what would be extra?
Ongoing care
What do refills, follow-up visits and any membership cost?
Leaving
What renews on its own, and what does cancelling involve?

What about insurance?

Ask your plan about the exact medicine, the reason it is being prescribed, tests and visits as separate items.

Get the plan’s answer in writing, including your share of the bill.

A cash quote is not an insurance decision.

What calls for a pause?

In guidance reviewed September 26, 2026, FDA labels claims of its approval for compounded medicines false or misleading.

FDA warns about online pharmacies that supply medicine without a prescription or have no pharmacist to answer questions.

Looks alone cannot settle it; fake storefronts can resemble licensed pharmacies.

Source e